Skip to main content

Day: May 29, 2024

Descartes Announces Fiscal 2025 First Quarter Financial Results

Record Revenues and Income from Operations WATERLOO, Ontario and ATLANTA, May 29, 2024 (GLOBE NEWSWIRE) —  The Descartes Systems Group Inc. (TSX:DSG) (Nasdaq:DSGX) announced its financial results for its fiscal 2025 first quarter (Q1FY25). All financial results referenced are in United States (US) currency and, unless otherwise indicated, are determined in accordance with US Generally Accepted Accounting Principles (GAAP). “Global trade is complex and constantly evolving. Supply chains and logistics operations continue to be impacted by a myriad of factors, including military conflicts, disruptions to trade routes, government sanctions, and material changes to taxes and tariffs,” said Edward J. Ryan, Descartes’ CEO. “Our technology solutions are designed to help shippers, carriers and logistics services...

Continue reading

Abcourt Announces its Results for the Third Quarter ended March 31, 2024

ROUYN-NORANDA, Quebec, May 29, 2024 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB : ABMBF) announces its results for the three months ended March 31, 2024. All monetary values in this press release are expressed in Canadian dollars, unless otherwise indicated. The financial statements and management report are available on SEDAR+. Highlights for the Quarter ended March 31, 2024 Exploration work totaling $1,765,615 for the quarter, exploration expenses incurred mainly on the Sleeping Giant property for the underground drilling campaign for an amount of approximately $1,709,229. Following the work carried out during the quarter, the Corporation confirmed the existence of a second gold mineralized zone to the east of the Flordin deposit towards the Cartwright deposit in the Lebel-sur-Quévillon...

Continue reading

Petrus Resources Declares Monthly Dividend for June 2024

CALGARY, Alberta, May 29, 2024 (GLOBE NEWSWIRE) — Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to confirm that its Board of Directors has declared a monthly dividend in the amount of $0.01 per share payable June 28, 2024, to shareholders of record on June 17, 2024. The dividend is designated as an eligible dividend for Canadian income tax purposes. ABOUT PETRUSPetrus is a public Canadian oil and gas company focused on property exploitation, strategic acquisitions and risk-managed exploration in Alberta. FOR FURTHER INFORMATION PLEASE CONTACT:Ken Gray President and Chief Executive Officer T: 403-930-0889 E: kgray@petrusresources.com

Continue reading

Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

CUPERTINO, Calif., May 29, 2024 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that it has closed its previously announced registered direct offering for the sale and issuance of 1,898,734 shares of the Company’s common stock and warrants to purchase up to 1,898,734 shares of common stock at a combined offering price of $1.58 per share of common stock and accompanying warrant priced at-the-market under the Nasdaq rules. The warrants have an exercise price of $1.455 per share, are immediately exercisable and will expire five years following the date of issuance. H.C. Wainwright &...

Continue reading

Voxtur Announces Financial Results for the Three Months Ended March 31, 2024

TORONTO and TAMPA, Fla., May 29, 2024 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) (“Voxtur” or the “Company”), a North American technology company creating a more transparent and accessible real estate lending ecosystem, today announced its financial results for the three months ended March 31, 2024. The Unaudited Condensed Interim Consolidated Financial Statements and the related Management’s Discussion and Analysis (“MD&A”) for the three months ended March 31, 2024, are available at www.sedarplus.ca and at www.voxtur.com. “We are pleased to report a strong start to 2024, showcasing our commitment to strategic financial management and innovation. Efforts on reducing the Company’s debt has been our primary focus, while also shifting resources towards...

Continue reading

Sow Good Signs Lease for New Distribution Facility in Dallas, Texas

New 324,000 sq. ft. Facility Expected to Significantly Increase In-House Production Capacity Dallas Facility Expected to House All Incoming Additional Freeze Driers IRVING, Texas, May 29, 2024 (GLOBE NEWSWIRE) — Sow Good, Inc. (Nasdaq: SOWG) (“Sow Good” or “the Company”), a trailblazer in the freeze-dried candy and treat industry, proudly announces a major expansion with a long-term lease for a new 324,000 sq. ft. production facility in Dallas, Texas. This strategic move is set to dramatically boost the Company’s production capacity, accelerating Sow Good’s ability to meet the soaring demand for its innovative freeze-dried treats. The state-of-the-art Dallas facility dedicates approximately 306,500 sq. ft. to production, packaging, and distribution, while reserving 17,400 sq. ft. for office space. This new hub will streamline...

Continue reading

X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinical Data from Ongoing Phase 2 Trial in Chronic Neutropenia

Webcast to include interim hematological results from at least 15 trial participants and feature experts in the treatment of chronic neutropenia BOSTON, May 29, 2024 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that it will host a virtual investor event on Thursday, June 27, 2024 at 8:00 am ET. To register for the event, click here. The event will focus on new interim results from an ongoing Phase 2 clinical trial exploring the use of mavorixafor as a once-daily oral treatment in patients with chronic neutropenia (CN). The data to be presented will include hematological results from at least 15 study participants treated with either mavorixafor monotherapy or mavorixafor in combination with stable doses of injectable...

Continue reading

ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference

BAUDETTE, Minn., May 29, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global Healthcare Conference in New York City as follows: Date: June 5, 2024     Time: 4:30 ET     Webcast: Click Here     To schedule a 1×1 meeting with the Company, please contact your Jefferies representative. About ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business...

Continue reading

OTTAWA BANCORP, INC. APPROVES STOCK REPURCHASE PROGRAM

OTTAWA, Ill., May 29, 2024 (GLOBE NEWSWIRE) — Ottawa Bancorp, Inc. (OTCQX: OTTW) (the “Company”), the holding company for OSB Community Bank (the “Bank”), announced today that the Company’s Board of Directors has approved a stock repurchase program authorizing the repurchase of 127,332 shares, or 5%, of the Company’s outstanding common stock. Stock repurchases will be conducted through open market purchases, which will include purchases under a trading plan adopted pursuant to Securities and Exchange Commission Rule 10b5-1, or through privately negotiated transactions. Repurchases will be made from time to time depending on market conditions and other factors. The Company’s stock repurchase program will terminate upon the completion of the purchase of 127,332 shares or on February 10, 2025 if not all shares have been purchased...

Continue reading

Earth Alive highlights a strong first quarter in 2024

MONTREAL, May 29, 2024 (GLOBE NEWSWIRE) — Earth Alive Clean Technologies Inc. (TSXV: EAC – “Earth Alive” or the “Company”), a company that develops, manufactures and distributes state-of-the-art, environmentally-sound proprietary microbial solutions and products, is pleased to announced today its financial results for the first quarter ended March 31, 2024. All amounts are in Canadian dollars unless otherwise indicated. Highlights of the First Quarter Sales totalled $1,301,021 in Q1 2024 compared to sales of $387,247 in Q1 2023 thanks to the acquisition of Interlube Inc. Total net loss of $1,333,569 compared to total net loss of $1,262,881 in Q1 2023 Total operating expenses of $1,552,451 compared to total operating expenses of $1,346,261 in Q1 2023 The working capital totaled $ 3,644,679 on March 31, 2024 with $2,013,090 in cash...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.